Guangzhou Medical University & AstraZeneca: Advancing understanding of COPD in China

Saturday, 26 September 2015

We’re working with Guangzhou Medical University, one of the world’s leading centres for research into respiratory disease, to advance the scientific understanding of Chronic Obstructive Pulmonary Disease (COPD).

Our team had previously carried out COPD studies in many western countries and was interested in comparing earlier findings with those from China, where COPD prevalence is high and rising rapidly. Our aim was to find better ways of diagnosing and preventing incidence.

The GMU hospital’s laboratory of respiratory disease conducted a two-year study into the reasons for disease progression by observing over 300 COPD patients and comparing them with healthy controls